Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Rhombencephalitis as a Rare Complication of COVID-19 Infection: A Case Report
Infectious Disease
Infectious Disease Posters (7:00 AM-5:00 PM)
058
We present a case of a 47 year old Caucasian male presenting with acute rhombencephalitis, two days following positive SARS-CoV-2 infection (COVID-19). Imaging revealed brainstem and posterior fossa inflammation. No other causes explained his neurological findings. This case is vital for the understanding of neurological inflammatory responses that can develop due to COVID-19 and may further pave the way for management.
Rhombencephalitis is a rare complication of infectious, autoimmune, and paraneoplastic syndromes. However, little is known about how COVID-19 neurologically manifests as the pandemic progresses. Our case highlights one of the first rare neurological complications due to an acute COVID-19 infection.

NA

Case and Management:

A 47 year old Caucasian male with a past history of uncontrolled hypertension presented to the emergency room in hypertensive emergency and diplopia which developed that morning. He reported four days of diarrhea, nausea, intermittent coughing, and feeling febrile. He tested positive for SARS-CoV-2 and a code stroke was initiated based on his presentation. CTA head and neck were negative for large vessel occlusion. Vitals and labs showed blood pressure at 225/123, WBC 13.2, LDH 185 and normal LFT. He was started on a Nicardipine drip. CSF analysis revealed pleocytosis with protein at 50, RBC 803, and glucose 101. MRI showed acute hemorrhagic leukorhombencephalitis with dilation of the fourth, third, and lateral ventricles. An External ventricular drain (EDV) was placed and he remained on a ventilator due to respiratory insufficiency. He underwent several rounds of plasmapheresis and high dose solumedrol for recovery.

We present a case of rhombencephalitis seen for the first time as a complication of an acute COVID-19 infection. Patients presenting with rhombencephalitis should have COVID-19 considered in the differential diagnoses as this will change patient management.
Authors/Disclosures
Stephanie C. Murti, DO (Georgetown)
PRESENTER
Ms. Murti has nothing to disclose.
No disclosure on file
Iftekhar Ahmed, MD, PC, FÂé¶¹´«Ã½Ó³»­ (HCA) Dr. Ahmed has nothing to disclose.